Skip to main content
. Author manuscript; available in PMC: 2021 Nov 29.
Published in final edited form as: Diabetes Care. 2020 Jul 2;43(9):2090–2097. doi: 10.2337/dc20-0495

Table 1.

Number of US adults aged ≥18 years beginning treatment for diabetes-related end-stage kidney disease, by race or ethnicity,* sex, age, and treatment modality, 2000 and 2016.

AIANs Asians Blacks Whites Hispanics
2000 2016 2000 2016 2000 2016 2000 2016 2000 2016
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Total 878 825 1,141 2,618 11,355 13,742 27,306 38,794 6,897 10,187
Sex
Male 397 440 602 1,546 4,800 7,054 14,282 22,755 3,451 5,890
(45.2) (53.3) (52.8) (59.1) (42.3) (51.3) (52.3) (58.7) (50.0) (57.8)
Female 481 385 539 1,072 6,555 6,688 13,024 16,039 3,446 4,297
(54.8) (46.7) (47.2) (40.9) (57.7) (48.7) (47.7) (41.3) (50.0) (42.2)
Age (years)
18–44 88 124 61 156 1,195 1,741 2,644 2,776 640 1,053
(10.0) (15.0) (5.3) (6.0) (10.5) (12.7) (9.7) (7.2) (9.3) (10.3)
45–64 514 422 438 944 5,450 6,294 10,848 15,665 3,372 4,927
(58.5) (51.2) (38.4) (36.1) (48.0) (45.8) (39.7) (40.4) (48.9) (48.4)
65–74 210 205 384 789 3,086 3,639 8,214 12,161 1,924 2,667
(23.9) (24.8) (33.7) (30.1) (27.2) (26.5) (30.1) (31.3) (27.9) (26.2)
≥75 66 74 258 729 1,624 2,068 5,600 8,192 961 1,540
(7.5) (9.0) (22.6) (27.8) (14.3) (15.0) (20.5) (21.1) (13.9) (15.1)
Treatment modality
Hemodialysis 802 754 1,030 2,241 10,698 12,689 24,361 34,800 6,413 9,290
(91.3) (91.4) (90.3) (85.6) (94.2) (92.3) (89.2) (89.7) (93.0) (91.2)
Peritoneal dialysis 70 68 97 356 586 1,000 2,457 3,636 433 845
(8.0) (8.2) (8.5) (13.6) (5.2) (7.3) (9.0) (9.4) (6.3) (8.3)
Transplant NA NA NA 20 22 48 299 318 17 46
(0.8) (0.2) (0.3) (1.1) (0.8) (0.2) (0.5)
Unknown NA NA NA -- 49 -- 189 40 34 --
(0.4) (0.7) (0.1) (0.5)
*

Racial groups include people of Hispanic and non-Hispanic origin; Hispanics may be of any race.

Cell size ≤10.

AIANs=American Indians and Alaska Natives; NA=not available.